CompletedPhase 3NCT02943902
Reduced PCV Dosing Schedules in South African Infants
Studying Pneumococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Witwatersrand, South Africa
- Principal Investigator
- Shabir A Madhi, MD, PhDUniversity of Witwatersrand, South Africa
- Intervention
- Pneumococcal conjugate vaccine (PCV10 ) 1+1, 6 weeks(biological)
- Enrollment
- 600 target
- Eligibility
- All sexes
- Timeline
- 2017 – 2019
Study locations (2)
- Chris Hani Baragwanath Academic Hospital, Johannesburg, Gauteng, South Africa
- Nrf/Dst Vpd Rmpru, Soweto, GP, South Africa
Collaborators
University College, London
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02943902 on ClinicalTrials.govOther trials for Pneumococcal meningitis
Additional recruiting or active studies for the same condition.